VIROPRO Inc., (OTCBB: VPRO)

Dear Reader:

Today, Viropro Inc. (OTCBB: VPRO) has announced that Trivor Financial Group I LP has committed to a $1 million financing to assist the company in its objective of expanding further in the burgeoning life science markets it has targeted.  The full details are included below for your review.

The figure of a million dollars, as astute investors well know, isn’t just a capital investment, it’s also a vote of confidence as it expresses faith in Viropro’s business plan by this benefactor.  As a company emerges, careful observers often watch to see how much new money a company can bring in as an indicator of “street” sentiment.  The first million, say some market pundits, is the most difficult to acquire and often the most critical to a company’s efforts. Clearly, this amount, though not garishly large by any stretch, must be seen as a positive event for a company in the early stages of a targeted plan to roll-up life science properties and to further penetrate vast health services and biotech markets in Canada, Brazil and beyond. 

As reported by StockUpTicks on Monday, Viropro is a stock we encourage you to watch… write the symbol down on a post-it, throw it in a “watchers” online portfolio, etc.  At the very least, this stock could be an interesting case study and practicum in biotech/health services investing.

Expect us to continue to monitor material events such as today’s financing news and to keep an eye on Viropro as it continues to execute its dynamic business plan.

**BREAKING NEWS** from Viropro

Press Release
Source: Viropro, Inc. Trivor Financial
Wednesday March 24, 11:14 am ET

MONTREAL--(BUSINESS WIRE)--March 24, 2004--Viropro, Inc. announced today that Trivor Financial Group I LP has committed to invest at least $1M US incrementally over the next several weeks to facilitate growth of Viropro's target acquisitions in the international Life Sciences sector. Trivor is also committed to working with Viropro as a lead funder for these and other acquisitions being contemplated. 

The Trivor Financial Group I LP is a Montreal-based private equity investment partnership establishing an investment portfolio of emerging companies with capital requirements and high growth potential in Healthcare and Biotechnology. 

Viropro's two initial acquisitions are expected to propel the company into revenue during 2004. One is a provider of products and services with an installed base in the Healthcare market. The other is a Biotech company with major agreements between partners in Canada, the US and Brazil involving both the purchase of licensed products for sale into Brazil (and possible technology transfer) and the licensing of products from Brazil for sales into North America. 

An agreement with another key investor is close to being finalized for investment into this Biotech initiative. Potential for this business, starting with major agreements, is substantial, with revenues expected to start during latter-part 2004. 

About Viropro, Inc. 
Viropro, Inc. (VPRO: OTCBB) is an emerging provider of management, product and technology solutions for international Life Sciences markets. The Company is seeking to establish a growth portfolio in Life Sciences through revenue-producing acquisitions with the potential for continued shareholder value. Through its growth, the Company also aims to facilitate the discovery and development of chemical and biological products and processes that will benefit medical science and increase the quality of life.

Viropro, Inc.'s Safe Harbor Statement 
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any
statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward looking statements". Forward looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors. 

Contact:
Trivor Financial Communications
Jerome Cliche, 514-876-1801
jcliche@trivor-inc.com

Source: Viropro, Inc. Trivor Financial
 

About Viropro Inc.

Viropro is an emerging provider of  management, product and technology solutions for the international Life Sciences markets.  One mission of the Company is to seek revenue-producing acquisition targets with the goal of establishing a new growth portfolio and a potential for continued shareholder value. On December 18, 2003, this culminated in a Letter of Intent to acquire CNC Holdings Inc.  Headquartered in Montreal, Canada, CNC Holdings Inc. develops and markets proven, innovative management solutions for the healthcare sector. 

The acquisition of CNC will immediately propel Viropro into two fast-growing segments of the life sciences market – healthcare and biotech. Other acquisitions and alliances are also contemplated in coming months. This acquisition will be concluded upon the completion of due diligence and the final confirmation of the S-4 Registration Statement that was filed with the SEC in February 2004.

The other mission at Viropro is the discovery and development of chemical and biological products and processes that will benefit medical science and increase the quality of life.

Viropro Financial Highlights

To Contact Viropro

---

*** The Bull is Running. ***
There may never be a better time to feature YOUR company
to over 1 MILLION investors.

To learn more about our programs email us directly at info@stockupticks.com

Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP).  The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness.  Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP has been compensated $17,500 by VPRO for preparation and distribution of this report and other advertising services.  This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company.  Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934 - Market Pathways 1920 Main Street, Suite 980, Irvine, CA  92614.  MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement.  Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results.  The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned.  Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.